Revolutionising Communication: Neuroprosthetic System Transforms Neural Activity into Speech for Paralyzed Individuals

By Michael Awood

August 30, 2023

In a pioneering study, researchers have created a multimodal speech neuroprosthetic system that could potentially restore full communication to those with severe paralysis. This innovative system decodes and converts neural activity into text, speech audio, and facial-avatar animation using high-density surface recordings of the speech cortex.

The system’s capabilities were demonstrated by a 47-year-old woman with severe limb and vocal paralysis caused by a basilar artery brainstem stroke. Despite her inability to vocalize or type, she achieved a median rate of 78 words per minute with a 25% word error rate using the neuroprosthetic system, significantly surpassing her previous rate of 14 words per minute using a commercial head-tracking system. The researchers even synthesized speech audio in her pre-injury voice and created a personalized avatar capable of realistic and interpretable speech and non-verbal facial gestures.

The neuroprosthetic system showed high performance within two weeks of training, outperforming previous brain-computer interfaces by four times in communication speed and twenty times in vocabulary size.

The study recognizes the need for further validation in other individuals with varying types of paralysis, as it is a proof-of-concept study based on a single patient. Future developments in electrode interfaces and real-time closed-loop feedback during decoding could improve user engagement, model performance, and neural entrainment.

This breakthrough offers immense potential for those living with paralysis. Improved communication through evolving technology could significantly enhance their quality of life by enabling meaningful interpersonal interactions.

The study participant expressed how this technology could enhance her daily life by improving expressivity, independence, and productivity. The ultimate goal is to integrate this technology seamlessly into real-world applications, offering hope to those living with speech loss due to severe paralysis.

Reference url

Recent Posts

340B Drug Pricing Lawsuit
      

Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA

🤔 How will ongoing legal battles shape the future of the 340B Drug Pricing Program?

Eli Lilly and Johnson & Johnson are challenging HRSA’s proposed rebate models, arguing that their approaches are essential for enhancing transparency and ensuring discounts directly benefit vulnerable patients. This crucial legal dispute highlights the tensions surrounding drug pricing regulations and could profoundly impact how discounts are provided to covered entities.

Dive into the details of these lawsuits and their implications for the pharmaceutical landscape.

#SyenzaNews #pharmaceuticals #healthcarepolicy #innovation #DrugPricing

WHO Investment Round 2023
    

WHO Investment Round: Securing Funding with Transparency Challenges

🌍 How can global health initiatives thrive with increased funding?

The WHO Investment Round is a pivotal initiative striving to secure $7.1 billion for essential health programs from 2025 to 2028. While achieving 53% of this target via diverse donor engagement, transparency in funding remains a challenge. Discover how these efforts can accelerate progress towards universal health coverage and tackle critical health issues like malaria and cervical cancer!

#SyenzaNews #globalhealth #universalhealthcoverage #healthcare #innovation

HPV vaccination South Africa
    

HPV vaccination South Africa: Cervical Cancer Prevention

🌍 How is South Africa leading the charge against cervical cancer?

Since launching its HPV vaccination program, the country has made remarkable strides in protecting future generations. With impressive coverage rates and a focus on at-risk populations, South Africa serves as a global model for effective public health strategies. Discover how this initiative not only combats cervical cancer but also addresses broader health concerns.

#SyenzaNews #HealthTech #GlobalHealth #HealthcareInnovation #CervicalCancer #HPVVaccination

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.